Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Yeshurun, Moshe; Labopin, Myriam; Blaise, Didier; Cornelissen, Jan; Sengeloev, Henrik; Vindelov, Lars; Kuball, Juergen; Chevallier, Patrice; Craddock, Charles; Socie, Gerard; Bilger, Karin; Schouten, Harry; Fegueux, Nathalie; GÖKER, HAKAN; Maertens, Johan; Bunjes, Donald; Arnold, Renate; Nagler, Arnon; Mohty, Mohamad

doi:10.1002/cncr.28498

Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Copy For Citation

Yeshurun M., Labopin M., Blaise D., Cornelissen J. J., Sengeloev H., Vindelov L., ...More

CANCER, vol.120, no.6, pp.855-863, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 120 Issue: 6
Publication Date: 2014
Doi Number: 10.1002/cncr.28498
Journal Name: CANCER
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.855-863
Hacettepe University Affiliated: Yes

Abstract

BACKGROUNDThe objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).